Health Opinion Research

Boundaries between normal and abnormal are often thin and blurred

Each individual's experiences, genetics, and environment create a unique mental health landscape. What may appear as a debilitating condition for one person could.

Read More
Health Medical Research

Understanding the social determinants of suicide mortality

HQ Team January 6, 2025: Suicide remains a pressing global public health issue, with over 700,000 deaths annually. A recent study highlighted significant social determinants.

Read More
Drugs Medical Research

Genetic testing offers hope against deadly C. auris infections

HQ Team January 4, 2025: A new study reveals that genetic testing can identify which antifungal drugs will effectively treat patients with Candida.

Read More
Opinion Research

Sense of bereavement and parasocial grief norms

Bharti Jayshankar January 4, 2024: A sense of bereavement is a common emotional response to the loss of a near and dear one..

Read More
Health Medical Research

Global prevalence of autism reaches 61.8 million: Study

HQ Team December 30, 2024: The global prevalence and health burden of autism spectrum disorder (ASD) are high, according to a review published.

Read More
Drugs Pharma Research

Study links gestational NSAID use to risk of childhood chronic kidney disease

HQ Team December 28, 2024: A study from Taiwan links the use of nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy, with a potential risk.

Read More
Health Medical Research

Study reveals early signs of Multiple Sclerosis in children

Bharti Jayshankar December 28, 2024: A recent research reveals that certain symptoms precede a diagnosis of multiple sclerosis (MS) in pediatric patients. The.

Read More
Drugs Health Medical Research

Vertex gets US regulator’s nod for extended use of cystic fibrosis drug

Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six.

Read More
Pharma Research

Clinical trial of AEF0217 for cognitive function in Down Syndrome shows promise

Bharti Jayshankar December 17, 2024: The ICOD (Improving Condition in Down Syndrome) project has reported promising findings from its phase 1/2 clinical trial.

Read More